Advertisement

Clinical Research Organizations - CRO News: Breaking Clinical Research Organizations - CRO News, Comments and Articles. - Page: 3

14:05 EDT 19th June 2013 | BioPortfolio

Clinical Research Organizations - CRO News - Page: 3 RSSTwitter

Read the latest Clinical Research Organizations - CRO News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Clinical Research Organizations - CRO.

Search or Follow Our Clinical Research Organizations - CRO - Page: 3 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Clinical Research Organizations - CRO - Page: 3 News.
You can also follow our Clinical Research Organizations - CRO - Page: 3 news stories on Twitter: @cro_bio

Showing "clinical research organization" News Articles 51 to 75 of 61,000+

Tuesday 18th June 2013

Call for overhaul of drug industry business model

LONDON (Reuters) - Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by investors says.

Ambrx, Zhejiang Medicine to develop antibody drug conjugate for breast cancer

US-based clinical stage biopharmaceutical company Ambrx and China-based Zhejiang Medicine have partnered for development and commercialisation of an antibody drug conjugate (ADC), ARX788.

Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments

Yale University researchers this week released the findings of two independent studies of Medtronic’s Infuse bone graft products. Parker Waichman, which offers free legal consultations for victims of Medtronic Infuse Bone Graft Injuries, notes that the results indicate that Infuse allegedly can cause cancer and male infertility, and that early published data was skewed toward the positive. New Y...

First Golden Goose Award of 2013 goes to Wallace Coulter

(Association of American Universities) The first 2013 Golden Goose Award will be awarded to the late Wallace H. Coulter, a researcher and inventor who some fifty years ago turned research on paint for the Navy into the Coulter Counter, which remains...

New research backs theory that genetic 'switches' play big role in human evolution

(Cornell University) A Cornell University study offers further proof that the divergence of humans from chimpanzees some 4 million to 6 million years ago was profoundly influenced by mutations to DNA sequences that play roles in turning genes on and...

No danger of cancer through gene therapy virus

(Helmholtz Association of German Research Centres) The first modified adeno-associated virus was recently approved for clinical gene therapy in the Western world. Scientists from the National Center for Tumor Diseases Heidelberg and the German Cancer...

Obese Children With Impaired Heart Function At Greater Risk Of Later Disease

Impaired heart function among obese children and adolescents may be an indicator of future heart disease, a new clinical trial finds. The results were presented at The Endocrine Society's 95th Annual Meeting in San Francisco. Obesity rates in develop...

Girls With Anorexia Nervosa Suffer Reduced Anxiety With Estrogen Replacement Therapy

Estrogen replacement therapy is associated with a significant decrease in anxiety symptoms among girls with anorexia nervosa, a new clinical trial finds. The results were presented today at The Endocrine Society's Annual Meeting in San Francisco...

New Target Timelines And Deadlines Increase Initiation Speed Of NCI Sponsored Clinical Trials

The National Cancer Institute (NCI) and investigators have reduced the deadlines for initiation of trials with the goal of reaching more patients in need of new treatments, according to a study published in the Journal of the National Cancer Institut...

Variants In The SIM1 Gene Associated With Severe Obesity

Although body weight is largely determined by lifestyle factors, increasingly research is revealing that genetics also play an important role in determining an individual's susceptibility to obesity. Identifying the mutations that underlie the fract...

Whole Exome Sequencing Seeks Out Adenoid Cystic Carcinoma

Adenoid cystic carcinoma (ACC) is a slow-growing and often fatal malignancy that can occur at multiple organ sites, but is most frequently found in the salivary glands. The primary treatment is surgical removal; however, the majority of patients deve...

After Uterus And Ovary Removal, Testosterone Therapy Improves Sexual Function

High doses of testosterone significantly improve sexual function among women who have had their uterus and ovaries surgically removed, a clinical study demonstrates. The results were presented at The Endocrine Society's 95th Annual Meeting in San Fra...

Marketing Unhealthy Foods To Children Is "Disastrous"

The marketing of unhealthy food to children has been disastrously effective and is only making childhood obesity even more of a problem, says The World Health Organization (WHO). WHO is calling for more control on marketing unhealthy foods high in su...

bluebird bio Announces Pricing of Initial Public Offering

bluebird bio, Inc., a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy, today announced the pricing of its initial public offering of 5,941,176 shares of common stock at a public offering price of $17.00 per share, before underwriting discounts. All of the common s...

Promising Research Presented on Yogurt's Effects on Weight Management and Chronic Disease

BETHESDA, Md., June 18, 2013 /PRNewswire/ -- There is a growing body of evidence linking yogurt consumption to improved health, and additional research to identify the scientific link between yogurt and potential health benefits is underway, scientists say. International nutrition experts gathered at the First Global Summit on the Health Effects of Yogurt in Boston on April 24, 2013 to presen...

Video: World Orphan Drug Congress USA 2013 event highlights

World Orphan Drug Congress USA is the largest international, commercially-focused event for the advancement of rare disease research and orphan drug development. Watch the event [...]

Obesity is a Disease: The American Medical Association Agrees with the American Association of Clinical Endocrinologists

The American Association of Clinical Endocrinologists (AACE) applauds the American Medical Association (AMA) House of Delegates for its action today to approve a resolution recognizing obesity as a disease state requiring a range of interventions to advance obesity treatment and prevention. AACE, the sponsor of the resolution, was joined by specialty and s...

June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy

Seven-year-old Riley Salz of Encino, California, is an example of how intensive applied behavior analysis (ABA) helps improve quality of life for individuals with autism; his family shares its personal journey through Center for Autism and Related Disorders “Mission Possible: Portraits of Hope.” Encino, CA (PRWEB) June 18, 2013 Seven-year-old Riley Salz of Encino, California, is on the road t...

Sun Buick GMC Sponsors Hole-In-One Contest For Maternal and Family Health Services Golf Tournament

Sun Buick GMC, Moosic, is sponsoring the hole-in-one contest at the Maternal and Family Health Services 20th Annual Golf Tournament on Thursday, June 20, at Irem Country Club, Dallas, Pennsylvania. Wilkes-Barre, Pennsylvania (PRWEB) June 18, 2013 Sun Buick GMC, Moosic, is sponsoring the hole-in-one contest at the Maternal and Family Health Services 20th Annual Golf Tournament on Thursday, June 20...

Video: Charles Shasky of Aetna on payers’ financial planning

Charles Shasky, Head of Pharmacoeconomic Comparative Effectiveness Research at Aetna, presented at World Orphan Drug Congress USA 2013 on the topic, ‘Optimizing payers’ financial planning [...]

Flash Mob Performed by the Cancer Center at The Children's Hospital of Philadelphia

The Flash Mob is Dedicated to Cancer Center Nurse Lisa Haffner (PRWEB) June 18, 2013 The Children’s Hospital of Philadelphia awarded Cancer Center nurse Lisa Haffner with the “Pitcher of Hope” during the Hospital’s 10th annual Alex’s Lemonade Stand Foundation kickoff event to benefit pediatric cancer research. As a childhood cancer survivor, Lisa Haffner has provided excellent medical...

Physician Resource Management Announces Douglas Blayney, M.D. as Senior Medical Advisor for the Organization

Douglas Blayney, M.D. Joins PRM Comprehensive Oncology Therapy Management Program Development Team (PRWEB) June 18, 2013 Physician Resource Management, Inc. (PRM) welcomes the addition of one of the nation’s leading oncologists, Douglas Blayney, M.D., to their management service organization. As Senior Medical Advisor for the organization, he will lead the development of clinically based protoc...

Alport Syndrome Foundation, Kidney Foundation of Canada Announce New Research Awards

PHOENIX—The Alport Syndrome Foundation (ASF) and The Kidney Foundation of Canada (KFOC)/Macquarie Research Fund are pleased to announce that they have awarded nearly $200,000 in joint funding for two Alport Syndrome research projects in 2013-2014.

INC Research Releases New White Paper on How Clinical Innovation Leads to Improved Predictability and Efficiency for Drug Development Programs

Paper offers innovative approaches to bringing drugs to market faster and reducing development costs Raleigh, N.C., June 18, 2013 - INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced it has released a new white paper titled, "Clinical Process Innovations for New Drug Development: Al...

Oxygen Biotherapeutics Reports Successful Completion of FDA Requested Immunocompetency Studies on Oxycyte®

Results from Safety Studies to be Submitted to FDA in July Oxygen Biotherapeutics, Inc. (“OBI”) (NASDAQ: OXBT), is a development stage biomedical company currently focused on developing its perfluorocarbon-based intravenous oxygen carrier, Oxycyte®, as a treatment for traumatic brain injury (TBI), stroke and other conditions where critical tissues...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement